Accessibility Menu
 
Acrux logo

Acrux

(ASX) ACR

Current Price$0.01
Market Cap$4.52M
Since IPO (2004)-98%
5 Year-93%
1 Year-50%
1 Month-8%

Acrux Financials at a Glance

Market Cap

$4.52M

Revenue (TTM)

$3.61M

Net Income (TTM)

$8.34M

EPS (TTM)

$-0.01

P/E Ratio

-1.90

Dividend

$0.00

Beta (Volatility)

0.08 (Low)

Price

$0.01

Volume

9,724

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.03

ACR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acrux

Industry

Pharmaceuticals

CEO

John Warmbrunn

Headquarters

West Melbourne, VIC 3003, AU

ACR Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

-2%

Net Income Margin

-84%

Return on Equity

-102%

Return on Capital

-2%

Return on Assets

-50%

Earnings Yield

-52.63%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.52M

Shares Outstanding

410.61M

Volume

9.72K

Short Interest

0.00%

Avg. Volume

271.88K

Financials (TTM)

Gross Profit

$1.19M

Operating Income

$8.97M

EBITDA

$5.17M

Operating Cash Flow

$5.47M

Capital Expenditure

$5.00K

Free Cash Flow

$5.48M

Cash & ST Invst.

$863.00K

Total Debt

$3.63M

Acrux Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.74M

-60.5%

Gross Profit

$1.52M

+166.7%

Gross Margin

87.24%

N/A

Market Cap

$4.52M

N/A

Market Cap/Employee

$105.04K

N/A

Employees

43

N/A

Net Income

$165.00K

+105.1%

EBITDA

$1.07M

+73.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$2.69M

-216.8%

Accounts Receivable

$1.63M

-58.6%

Inventory

$0.00

N/A

Long Term Debt

$2.88M

+47.6%

Short Term Debt

$756.00K

+23.9%

Return on Assets

-49.76%

N/A

Return on Invested Capital

-1.94%

N/A

Free Cash Flow

$4.16M

-311.1%

Operating Cash Flow

$4.18M

-300.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IBX.AXImagion Biosystems Limited
$0.02-4.35%
BIT.AXBiotron Limited
$0.00+20.00%
GLH.AXGlobal Health Limited
$0.07+0.00%
ZLD.AXZelira Therapeutics Limited
$0.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CRWVCoreWeave
$103.74+0.13%
NOKNokia
$9.52-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.43-0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.38+0.01%

Questions About ACR

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.